Immunomodulating activities of cocaine--evaluation of lymphocyte transformation related to other immune functions.
Cocaine dosages ranging from 2.5 mg/kg/day to a highly toxic dose of 50 mg/kg/day were injected intramuscularly or intraperitoneally into different groups of mice for 4-10 days. The effects of cocaine were evaluated by tumor growth, lymphocyte transformation, phagocytosis, and IgM plaque-forming cells. At all dosages, including toxic doses, cocaine does not inhibit lymphocyte transformation of the splenic or the peripheral blood lymphocytes. However, all other immunological parameters of the same animal were suppressed. These results suggest that lymphocyte transformation may not be a proper indicator for the immune status of mice treated with cocaine. The same may be true when testing human drug abusers.
Shen
M L
ML
Department of Pathology, University of Illinois at Chicago 60612.
Luo
Y D
YD
Hagen
K
K
Wu
Y B
YB
Ou
D
D
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D015415:Biomarkers; D003042:Cocaine / Q000494:pharmacology*; D004912:Erythrocytes / Q000276:immunology; D005434:Flow Cytometry; D006462:Hemolytic Plaque Technique; D007111:Immunity, Cellular / Q000187:drug effects*; D007075:Immunoglobulin M / Q000276:immunology; D066298:In Vitro Techniques; D008213:Lymphocyte Activation / Q000187:drug effects*; D051379:Mice; D008810:Mice, Inbred C57BL; D008934:Mitogens / Q000494:pharmacology; D009368:Neoplasm Transplantation; D010587:Phagocytosis / Q000187:drug effects; D010954:Plasmacytoma / Q000276:immunology; D013154:Spleen / Q000166:cytology / Q000276:immunology
D000276:Adjuvants, Immunologic; D015415:Biomarkers; D007075:Immunoglobulin M; D008934:Mitogens; D003042:Cocaine